Developmental alteration of endocannabinoid retrograde signaling in the hippocampus

Journal of Neurophysiology

Volumn 103, Issue 2, 2010, Pages 1123-1129

  Zhu, Ping Jun ^a   Lovinger, David M ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID; 6 METHYL 2 (PHENYLETHYNYL) PYRIDINE; ENDOCANNABINOID; METABOTROPIC RECEPTOR; MUSCARINIC RECEPTOR; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN SLICE; CONTROLLED STUDY; DEPOLARIZATION; HIPPOCAMPUS; LEARNING; MATURATION; MEMORY; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NEWBORN PERIOD; NONHUMAN; PATCH CLAMP; PERINATAL PERIOD; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STIMULATION; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION; WHOLE CELL;

ACTION POTENTIALS; AGING; ANIMALS; ANIMALS, NEWBORN; ENDOCANNABINOIDS; HIPPOCAMPUS; NEURONAL PLASTICITY; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION;

EID: 76649129302     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00327.2009     Document Type: Article

References (40)

1. Bolshakov VY, Siegelbaum SA. Postsynaptic induction and presynaptic expression of hippocampal long-term depression. Science 264: 1148-1152, 1994.
2. Carlson G, Wang Y, Alger BE. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat Neurosci 5: 723-724, 2002.
3. Chevaleyre V, Castillo PE. Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38: 461-72, 2003.
4. Collard KJ, Edwards R, Liu Y. Changes in synaptosomal glutamate release during postnatal development in the rat hippocampus and cortex. Brain Res 71: 37-43, 1993.
5. Defagot MC, Villar MJ, Antonelli MC. Differential localization of metabotropic glutamate receptors during postnatal development. Dev Neurosci 24: 272-282, 2002.
6. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949, 1992.
7. Dumas TC, Foster TC. Developmental increase in CA3-CA1 presynaptic function in the hippocampal slice. J Neurophysiol 73: 1821-1828, 1995.
8. Fuenzalida M, Aliaga E, Olivares V, Roncagliolo M, Bonansco C. Developmental increase of asynchronic glutamate release from hippocampal synapses in mutant taiep rat. Synapse 63: 502-509, 2009.
9. Gaoni Y, Mechoulam R. The isolation and structure of delta-1-tetrahydro-cannabinol and other neutral cannabinoids from hashish. J Am Chem Soc 93: 217-224, 1971.
10. Gasparini S, Saviane C, Voronin LL, Cherubini E. Silent synapses in the developing hippocampus: lack of functional AMPA receptors or low probability of glutamate release? Proc Natl Acad Sci USA 97: 9741-9746, 2000.
11. Harris KM, Teyler TJ. Developmental onset of long-term potentiation in area CA1 of the rat hippocampus. J Physiol 346: 27-48, 1984.
12. Hentges ST, Low MJ, Williams JT. Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. J Neurosci 25: 9746-9751, 2005.
13. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87: 1932-1936, 1990.
14. Iwasaki S, Takahashi T. Developmental regulation of transmitter release at the calyx of Held in rat auditory brain stem. J Physiol 534: 861-871, 2001.
15. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544-4558, 1999.
16. Kim J, Isokawa M, Ledent C, Alger BE. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 22: 10182-10191, 2002.
17. Kramar EA, Lynch G. Developmental and regional differences in the consolidation of long-term potentiation. Neuroscience 118: 387-398, 2003.
18. Leinekugel X, Khalilov I, McLean H, Caillard O, Gaiarsa JL, Ben-Ari Y, Khazipov R. GABA is the principal fast-acting excitatory transmitter in the neonatal brain. Adv Neurol 79: 189-201, 1999.
19. Lenz RA, Wagner JJ, Alger BE. N- and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. J Physiol 512: 61-73, 1998.
20. Lujan R, Roberts JD, Shigemoto R, Ohishi H, Somogyi P. Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites. J Chem Neuroanat 13: 219-241, 1997.
21. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansberger W, Di Marzo V, Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534, 2002.
22. Martin LA, Alger BE. Muscarinic facilitation of the occurrence of depolarization-induced suppression of inhibition in rat hippocampus. Neuroscience 92: 61-71, 1999.
23. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564, 1990.
24. Morishita W, Alger BE. Sr2+ supports depolarization-induced suppression of inhibition and provides new evidence for a presynaptic expression mechanism in rat hippocampal slices. J Physiol 505: 307-317, 1997.
25. Morozov YM, Freund TF. Post-natal development of type 1 cannabinoid receptor immunoreactivity in the rat hippocampus. Eur J Neurosci 18: 1213-1222, 2003.
26. Neu A, Foldy C, Soltesz I. Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J Physiol 578: 233-247, 2007.
27. Ohno-Shosaku T, Maejima T, Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29: 729-738, 2001.
28. Ohno-Shosaku T, Shosaku J, Tsubokawa H, Kano M. Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur J Neurosci 15: 953-961, 2002.
29. A responses in hippocampal pyramidal cells. J Neurosci 12: 4122-4132, 1992.
30. Stella N, Piomelli D. Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur J Pharmacol 425: 189-196, 2001.
31. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophysical Res Com 215: 89-97, 1995.
32. Sullivan JM. Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn Mem 7: 132-139, 2000.
33. Tsou K, Mackie K, Sanudo-Pena MC, Walker JM. Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience 93: 969-975, 1999.
34. Varma N, Carlson GC, Ledent C, Alger BE. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21: RC188, 2001.
35. Wasling P, Hanse E, Gustafsson B. Developmental changes in release properties of the CA3-CA1 glutamate synapse in rat hippocampus. J Neurophysiol 92: 2714-2724, 2004.
36. Wigstrom H, Gustafsson B. Facilitation of hippocampal long-lasting potentiation by GABA antagonists. Acta Physiol Scand 125: 159-172, 1985.
37. Wilson RI, Kunos G, Nicoll RA. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31: 453-462, 2001.
38. Wilson RI, Nicoll RA. Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature 410: 588-592, 2001.
39. Yanovsky Y, Mades S, Misgeld U. Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra. Neuroscience 122: 317-328, 2003.
40. Zhu PJ, Lovinger DM. Persistent synaptic activity produces long-lasting enhancement of endocannabinoid modulation and alters long-term synaptic plasticity. J Neurophysiol 97: 4386-4389, 2007.